Cellular Immunology provides an international medium devoted exclusively to publication of original investigations concerned with the immunological activities of cells in experimental or clinical situations. The scope of the journal encompasses the broad area of in vitro and in vivo studies of cellular immune responses. These include, for example, delayed-type hypersensitivity or cellular immunity; immunologic surveillance and tumor immunity; transplantation immunology; autoimmunity, resistance to intracellular microbial and viral infection; immunologic deficiency states and their reconstitution; antigen receptor sites; thymus and lymphocyte immunobiology, etc. The chief criteria for acceptance of papers submitted for publication are the originality, clarity, and quality of the work reported.

Submission of Manuscripts

It is a condition of publication that all manuscripts must be written in clear and grammatical English and be submitted to the Cellular Immunology Web site at http://ees.elsevier.com/cimm. Minimal exceptions will be allowed. If you are unable to provide an electronic version of your paper, please contact the Editorial Office prior to submission (e-mail: ci@elsevier.com; telephone; (619) 699-6404; fax: (619) 699-6859).

Each manuscript is to be accompanied by an electronic cover letter outlining the basic findings of the paper and their significance. PDFs of all related manuscripts under consideration for publication must also be included with the submitted manuscript.

Authors should suggest at least four competent reviewers in their field and may also suggest individuals whom they wish to have excluded from the review process. The list of suggested reviewers should be compiled as a separate document.

There is no submission fees or page charges.

Language Polishing. Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/wps/find/authorshome.authors/languagepolishing or contact authorsupport@elsevier.com for more information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our Therms and Conditions http://www.elsevier.com/wps/find/termconditions.cws_home/termconditions

Manuscripts are accepted for review with the understanding that no substantial portion of the study has been published or is under consideration for publication elsewhere and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out. Manuscripts that do not meet the general criteria or standards for publication in Cellular Immunology will be immediately returned to the authors, without detailed review.

Upon acceptance of an article, authors will be asked to sign a "Journal Publishing Agreement" (for more information on this and copyright see http://authors.elsevier.com). Acceptance of the agreement wil ensure the widest possible dissemination of information. An email (or letter) will be sent to the corresponding author confirming receipt of the manuscript together with a "Journal Publishing Agreement" form.
If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights Department, Oxford, UK; phone:(+44) 1865 843830, fax (+44) 1865 853333, email:permissions@elsevier.com. Requests may also be completed online via the Elsevier homepage ( http://www.elsevier.com/locate/permissions).

Types of Articles

Full-length articles are full-length descriptions of original research. The scope may include basic science, clinical results, or applications. These manuscripts will undergo standard review and normally are not expedited.

Reviews are comprehensive appraisals of research and clinical outcomes in a field of current interest. All reviews are subject to the normal review process. Please consult with the Editor-in-Chief regarding content and length prior to submission.

Rapid Communications are brief, definitive reports of highly significant and timely findings in the field. At the discretion of the Editor, these submissions receive very rapid review and, if acceptable, are published within an average of 2 months from receipt. In general, manuscripts should be no longer than 12 double-spaced typewritten pages, containing an abstract of approximately 100 words followed by keywords, a one-paragraph introduction, an abbreviated Materials and Methods, Results, and a concise Discussion. A maximum of 20 references and four items for the display of data (any combination of figures and tables) will be allowed. Rapid Communications will be reviewed within 1 to 2 weeks. No significant revisions will be permitted. Rapid Communications will appear in a special section at the front of the journal.

Letters to the Editor relating to articles appearing in Cellular Immunology are welcome and will be published, if found suitable, as limited space permits. All letters must be in the format of other material submitted for publication and limited in length to two typewritten pages.

Preparation of Manuscript

Manuscripts should be double-spaced throughout. Pages should be numbered consecutively and organized as follows:

The Title Page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers).

The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 150 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.

The Introduction should be as concise as possible, without subheadings.

Materials and methods should be sufficiently detailed to enable the experiments to be reproduced.

Results and Discussion may be combined and may be organized into subheadings.

Acknowledgments should be brief and should precede the references.

References should be cited in the text by a number in square brackets and listed at the end of the paper in numerical order. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text. Please note the following examples:

[1] S. Najib, V. Sanchez-Margalet, Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway, Cell. Immunol. 220 (2002) 143-149.

[2] D.H. Katz, Lymphocyte Differentiation, Recognition, and Regulation, Academic Press, New York, 1977.

[3] O.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: E.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 1999, pp. 281-304.

Figures

Number figures consecutively with Arabic numerals. Please visit our Web site at http://authors.elsevier.com/artwork for detailed instructions on preparing electronic artwork.

Free color figures. Color figures will be published free of charge, both on the Web (e.g. ScienceDirect and other sites) and in the printed article. Please Please make sure the artwork is an acceptable format (TIFF, EPS, or MS Office files) and is at the correct resolution. For further information on the preparation of electonic artwork, please see http://authors.elsevier.com/artwork
.

Tables

Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below.

Preparation of Supplementary Material

Elsevier now accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer additional possibilities for publishing supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips, and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect (http://www.sciencedirect.com). To ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Please note, however, that supplementary material will not appear in the printed journal. Files can be stored on 3.5-inch diskette, ZIP disk, or CD (either MS-DOS or Macintosh). For more detailed instructions, please contact the Editorial Office prior to submission (e-mail: ci@elsevier.com; telephone; (619) 699-6404; fax: (619) 699-6859.

Proofs

PDF proofs will be e-mailed to the corresponding author. To avoid delay in publication, only necessary changes should be made, and corrections should be returned promptly. Authors will be charged for alterations that exceed 10% of the total cost of composition.

Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 50 free paper offprints. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Additional paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.

Author Inquiries

For inquiries relating to the submission of articles (including electronic submission where available) please visit http://authors.elsevier.com. This Web site also provides information on how to track accepted articles and set up e-mail alerts to inform you of when an article's status has changed, as well as copyright information, frequently asked questions, and more. For detailed artwork guidelines, please consult http://www.elsevier.com/artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication.

Sponsored Articles:
Cellular Immunology offers authors or their institutions the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please click here.